Ancillary testing in prostate cancer: Difference between revisions

Revision as of 15:07, 1 November 2022

Ancillary testing in prostate cancer is evolving. Prostate cancer panel redirect here.

Revision as of 15:06, 1 November 2022 view source Michael (talk \| contribs) 49,325 edits create		Revision as of 15:07, 1 November 2022 view source Michael (talk \| contribs) 49,325 edits →References Newer edit →
Line 7:		Line 7:
	{{Reflist\|1}}		{{Reflist\|1}}

	[[Category:~~Uropathology~~]]		[[Category:Genitourinary pathology]]